Skip to main content

Table 3 Multivariate regression analyses of factors associated with serum FGF23 levels

From: Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus

Variable

Standardized β

t

P

Model 1

 W

0.119

2.411

0.016

 F-IMT

0.175

3.582

<0.001

Model 2 (adjusted for gender)

 W

0.115

2.335

0.020

 F-IMT

0.184

3.748

<0.001

Model 3 (adjusted for Ca, P, and GFR)

 W

0.134

2.717

0.007

 F-IMT

0.184

3.485

0.001

  1. Original variables included: age, FCP, 2hCP, W, and F-IMT
  2. FCP fasting C-peptide, 2hCP 2-hour C-peptide, W waist circumference, F-IMT femoral intima-media thickness